CBI Arrests CBN Inspector, Middleman For Taking Rs 3 Lakh Bribe In Rajasthan

Chittorgarh:  The Central Bureau of Investigation (CBI) has arrested an inspector of the Central Narcotics Bureau (CBN) of Chittorgarh and a middleman while taking bribe. A bribe of Rs 20 lakh was demanded to settle a case against a clinic. The accused inspector has been caught taking a bribe of Rs 3 lakh through a middleman. At present, the CBI team is busy interrogating both the accused.(Video)

The complainant filed a complaint with the Central Bureau of Investigation (CBI). In this, the inspector of the Central Narcotics Bureau (CBN) of Chittorgarh is demanding a bribe of Rs 3 lakh through a middleman. The bribe amount is being demanded by the accused to settle the case against his clinic. A bribe of Rs 20 lakh was demanded to settle the case. After that, a bribe of Rs 8 lakh was demanded by the accused.

On the complaint, a case was registered on Wednesday against the accused Inspector Adarsh ​​Yogi of the Central Narcotics Bureau and middleman Keshav. Then the CBI laid a trap and caught the middleman Keshav red-handed while taking a bribe of Rs 3 lakh from Chittorgarh NCB Inspector Adarsh ​​Yogi. During the search, the team also found many objectionable documents, which were seized by the CBI. At present, the CBI team is busy interrogating both the accused.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit